In addition, the rs6702619 polymorphism was demonstrated to be located on a distal-acting enhancer of PALMD gene, affecting the regulation of the gene and promoting fibrosis, which is another pathological process involved in CAVD (40). The gene discussed is PALMD; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.